midazolam has been researched along with ivosidenib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bolleddula, J; Ke, A; Prakash, C; Yang, H | 1 |
1 other study(ies) available for midazolam and ivosidenib
Article | Year |
---|---|
PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caco-2 Cells; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Female; Glycine; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Membrane Transport Proteins; Midazolam; Models, Biological; Pyridines; Sulfonamides | 2021 |